chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Have been feeling worn out and tired ever since.; This is a spontaneous report from a contactable consumer. A 60-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Feb2021 at 14:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in Feb2021 at 15:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 24Feb2021 at 14:30, the patient had been feeling worn out and tired and for the last 6 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event had been feeling worn out and tired was resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
9AM w/in 1/2hr of receiving vax student displayed hives, blotchy, raised areas on face, neck & upper arms;mom was contacted;DPH given;student dismissed;completely recovered;
?COVID arm?. Itchy red rash developed on arm where vaccination was administered. Rash developed 7 days after injection.  day two of rash measuring about 4x4 inches. Rash is bright red, firm and hot to the touch.
Fever; chills; This is a spontaneous report from a contactable nurse (patient). A 46-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231), intramuscular on 24Dec2020 14:30 (reported as "02:30 PM") at single dose on left arm as COVID vaccine. Patient was not pregnant.  Medical history included asthma and hypothyoridism. The patient was diagnosed with COVID-19 prior to vaccination.  Concomitant medications included levothyroxine sodium (SYNTHROID), fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), reported as "Other medications in twoweeks: synthroid, Breo".  The patient previously took cefalexin (KEFLEX) and experienced allergies. The patient experienced fever and chills on 25Dec2020 at "08:00PM". The events were assessed as non-serious. No treatment was given. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was recovered on an unspecified date.
Numbness, tingling, loss of vision on the right side of body.  Arm parasthesia resolving as of 9-1-15.  Was seen at Hospital, MRI negative. Seeing a pediatric neurologist at Hospital 9-1-2015.
Presented to clinic with varicella type rash on trunk, number of lesions was greater than 12.  Follow-up - Vaccine Lot# 1654H - Record updated.
Paralysis of her whole body for 30 seconds; This spontaneous case was reported by a consumer and describes the occurrence of PARALYSIS (Paralysis of her whole body for 30 seconds) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 immunisation.     The patient's past medical history included No adverse effect (no medical history reported.).    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PARALYSIS (Paralysis of her whole body for 30 seconds) (seriousness criterion medically significant). On 24-Mar-2021, PARALYSIS (Paralysis of her whole body for 30 seconds) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
I developed palsy in my face within an hour of the injection. My eye was drooping, I had numbness and my mouth was drooping. By that evening, I started experiencing clotting. I blew my nose and had a golf ball sized clot come out. The palsy lasted to the next day. I didn't go to get care at the ER right away because of my worries with COVID. I kept having regular nose bleeds and then clotting which made me go get care. I received care from my ENT twice in one week. They did an outpatient endoscopy to stop the bleeding in my nose. I still had to go to the ER because I was still experiencing other ways of bleeding. I started my menstrual cycle and it was not normal for it to start when it did. At the ER, they performed multiple tests. I was passing a lot of clots during my cycle. My neurologist recommended that I should not get the booster shot because of what has happened. I did have these same reactions after the first dose, except they were milder.
Pt recvd MMR vax on 30JUN84 & on 1FEB92 pt devel viral illness & presented to a  MD for tx; 4FEB92 devel maculopapular pruritic rash on face; exp loss of appetite & devel a fever & bloodshot eyes; dx measles;
Aches, chills, fever of 101.5, loss of appetite, extremely tired, headache, vomiting one time
Patient started not feeling well Monday night, states no appetite, chills, arm is very swollen, red, hot to the touch and sore to touch. It has been 4 days and swelling has not gone down. Patient is taking BENADRYL and using ice to resolve swelling.
I am laying here with three breaks in my back, where we can get Pfizer injection for Covid.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 77-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SPINAL FRACTURE (medically significant), outcome "unknown", described as "I am laying here with three breaks in my back, where we can get Pfizer injection for Covid.".  Clinical course: Patient asked for help locating Pfizer covid 19 vaccine 2023-2024 formula in privacy area. Caller stated that they always had Pfizer (Covid 19 vaccine and they don't want Moderna) Can not find in Privacy area heard that is not certified yet, where they can get it. Patient stated she was laying here with three breaks in her back, where they can get Pfizer injection for Covid she asked. husband will be 84 in couple of months. Patient was asking for the availability of the Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula).  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
ROTATEQ that underwent the temperature excursion could have been administered to patients.; No additional AE's.; This spontaneous report was received from a licensed practical nurse and refers to am unknown number patients of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies was provided.  On an unknown date, the patients was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) orally, lot # T033510 with expiration date of 28-DEC-2021, for prophylaxis (specific dose was not reported).  No adverse effects were reported.    It was stated that the vaccines underwent a temperature excursion of 2°C to 8°C (8.7°C) for 0 hours 52 minutes 30 seconds; (8.7°C) for 0 hours 21 minutes 0 seconds; and 2°C to 8°C (8.7°C) for 0 hours 52 minutes 30 seconds; (8.7°C) for 0 hours 21 minutes 0 seconds. No previous temperature excursion was done. The call was because of a "data logger".  No further information provided.            On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).
Body ache; Fatigue; Chills; Fever 102; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever 102) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced MYALGIA (Body ache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever 102). At the time of the report, MYALGIA (Body ache), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Body temperature: 102.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment medication included acetaminophen 4-6 daily.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Information has been received from a medical assistant concerning a 68 year old male patient with charcot's joint, bilaterally of the feet, peripheral neuropathy, osteomyelitis and seasonal allergies who on 09-OCT-2006 was vaccinated intramuscularly in the right arm with a 0.5 mL dose of Pneumovax 23 (Lot# 651400/0618F). Concomitant therapy included AMBIEN, omega-3 triglycerides, CENTRUM and garlic pills. On 09-OCT-2006 the patient experienced pain in the arm. Follow-up information from the reporter further indicated that on 09-OCT-2006 at approximately 6:40 PM, the patient experienced swelling and redness from the shoulder to below elbow, the area felt very hot and as swelling progressed, it settled in inner part of elbow. There was no illness at the time of vaccination. The reporter stated: "The patient also feels like he is coming down with a cold on the morning of 10/10/06." Follow-up from the reporter indicated that it took about two weeks (approximately 23-OCT-2006) before pain, soreness, and swelling resided. The patient was reported as recovered. The treatment was ice and ibuprofen. Additional information is not expected.
15 year old vaccinated due to Nurse not catching age of the patient prior. DOB was listed incorrectly and patient vaccinated before correction.
Booster (not an option on pull down,.  Listed as dose 3, but this was booster volume.) -- The day after this vaccination the patient reports waking up with chills and by afternoon was experiencing dizziness, nausea, and sweating.  She also had a local reaction at the injection site which measured 2-1/4 inches in diameter that was red, hot, hard, and painful.
Extreme neck, shoulder, back pain on 1/5/22, could barely turn neck.  On 1/6/22 neck/back improving but noticed supraclavicular lymph node on right side extremely swollen,  huge lump
10 x 10 mm swelling at injection site.  Signs and symptoms worsened over the next 48 hours.
1. Patient was administered Pfizer monovalent Covid vaccine after the authorization for use expired April 18, 2023. 2. Patient was prescribed Pfizer Bivalent and was administered Pfizer monovalent in error.
I felt worse than when I began covid in Dec. Temp up to 102, achy  body, just felt terrible
The initial symptoms started 10 days after I received the 2nd Pfizer Vaccine. The initial symptom that I noticed was tingling in my left toes (specifically my left big toe). Over the next couple days that progressed to where the tingling sensation had moved farther up my leg (up to my calf) and it also would turn in to a pretty severe burning sensation later in the evening/night. Around the same time period I began waking up in the middle of the night with my arms/hands & feet/legs feeling like they had fallen asleep even though I hadn't been laying on them. My left side was most impacted by the tingling/burning, with my right hand being least impacted. I also developed very noticeable twitching all over my body (from my feet all the way up to my neck/shoulders). My hands and feet were also much quicker to reach the feeling of "falling asleep" even when sitting in normal positions.   At this point I made an appoint with my PCP who ran some bloodwork and prescribed me Gabapentin to see if that would help with the symptoms. His opinion was that it was likely a "mild" adverse reaction to the vaccine that caused neuropathy and that I should give it some time to see if things improved.   Unfortunately, the symptoms became worse over the next week and a half. The burning sensation become worse which greatly impacted my sleep and I felt very weak (minimal movement would make me feel like I had worked out). At the point we made the decision to visit the emergency room where I stayed for ~2 days.   After being discharged from the hospital the symptoms changed some over the next few weeks (through weeks 4-8). The tingling and burning became less noticeable, however, I started having deep cramping sensation pains/aches(though the muscles weren't actually cramping). I would get those pains randomly from the bottom of my feet all the way up to my neck/jaw. I also had a couple weeks where I would have some pretty severe pain in my left elbow and neck when I would move my hands/head certain directions. I also developed a buzzing/vibrating type sensation in my lower back area that would happen pretty consistently throughout the day as well as an uncomfortable spasm sensation in my right hamstring. The twitching at this point was also still very noticeable.   I am still currently dealing with some symptoms almost 4 months later, however, I would say they are less severe and I have regained most of my strength. My remaining symptoms are as follows: - Mild cramping sensations all over body (typically bottom of feet, calves, and pads of hands). These are less severe than before - Mild twitching that can occur all over - Consistent/constant dull burning sensation on left lower leg (above ankle) - Limbs feel more shaky than before (especially fingers/hands)
Administered dose with the temperature excursion issue; Inappropriate schedule of vaccine administered; Administered dose with the temperature excursion issue; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered dose with the temperature excursion issue), PRODUCT TEMPERATURE EXCURSION ISSUE (Administered dose with the temperature excursion issue) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Jan-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 21-Mar-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 21-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered dose with the temperature excursion issue) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Administered dose with the temperature excursion issue). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered dose with the temperature excursion issue), PRODUCT TEMPERATURE EXCURSION ISSUE (Administered dose with the temperature excursion issue) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Only lot number 059H21A, thawed on 28-Jan-2022 was affected lot 084J21A was not put into use until 10-Feb-2022. On 28-Jan-2022 temp ranged from 34.7F to 41.2F, on 30-Jan-2022 34.7F to 41.2F which occurred approximately for 48 hours; on 31-Jan-2022 34.7F to 41.2F for 12 hours and on 04-Feb-2022 35.2F to 41.7F for 12 hours.  No treatment medication was reported by reporter.  No patient reported any adverse event.
Information has been received from a consumer concerning her 4 month old daughter with no previous medical history and allergies reported who "around June 2008", was vaccinated with the second dose of ROTATEQ and "received other vaccination, but did not remember the names".  It was reported that "around 6 months of age (approximately in October 2008), the patient had developed an ear infection and because of the infection and was with antibiotics (name and manufacturer unspecified) she did not receive the third dose of ROTATEQ at 32 weeks of age".  The consumer reported that at the time of the report, the patient had not yet receive the third dose of ROTATEQ.  The reporter wanted to check what will happen if her daughter never received the third dose of ROTATEQ and was already 33 weeks old.  On an unspecified date, the patient recovered from ear infection.  The patient sought unspecified medical attention.  Additional information has been requested.
shingles, started in right eye,  then right side of face, up to top of head.   intense pain,  swollen eye lids, lot of bumps/rash  Treating with Valacyclovir  and Erythromycin for the eyes  started 1 month after 2nd Pfizer vaccination.
Extreme dizziness or vertigo, feeling cross eyed, extreme fatigue, tinnitus or ringing in ears, headaches, ear aches, sore muscles
Pt recvd 3 doses of Engerix-B; 3-4 months p/last inject tested neg for antibody production;
patient states about 4 days after recieving the vaccine, he noticed itching on multiple areas of the body. Scalp, wrist, lower back being the worst. No rash apparent. Benadryl gave him a headache after 1 dose. Patient discontinued. Advised patient to contact PCP to rule out other causes. Advised using cetirizine 10mg daily to see if sx subside
When he touches it, it's hot; He may have received a shot in his bone, not the muscle; Shot site is itching a lot; Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), VACCINATION SITE WARMTH (When he touches it, it's hot), FEELING ABNORMAL (He may have received a shot in his bone, not the muscle) and VACCINATION SITE PRURITUS (Shot site is itching a lot) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 017B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced PAIN (Pain). On an unknown date, the patient experienced VACCINATION SITE WARMTH (When he touches it, it's hot), FEELING ABNORMAL (He may have received a shot in his bone, not the muscle) and VACCINATION SITE PRURITUS (Shot site is itching a lot). At the time of the report, PAIN (Pain), VACCINATION SITE WARMTH (When he touches it, it's hot), FEELING ABNORMAL (He may have received a shot in his bone, not the muscle) and VACCINATION SITE PRURITUS (Shot site is itching a lot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were reported.    No treatment information was provided.
Headache, SORE, FATIGUE, CHILLS Narrative: REPORTS SORENESS FATIGUE DAY 2 OF FIRST DOSE AS WELL, AND RASH 2 WEEKS LATER AND HA 4 WEEKS LATER
swollen crusty eyelids; swollen crusty eyelids; This spontaneous report as received from a pharmacist refers to a 43-year-old female patient. The patient's pertinent medical history included multiple sclerosis. The patient's concurrent conditions included allergy to morphine, prednisone, metoclopramide (REGLAN) and sumatriptan (IMITREX). The patient's concomitant medications were not reported.  On 27-JUN-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) lot # R011809, expiration date 23-APR-2020, subcutaneously for routine vaccination (dose and frequency were not reported). On 28-JUN-2019, the patient experienced swollen crusty eyelids. The events recovered on an unknown date in July 2019 (reported as maybe 3 or 4 days after starting).  The relatedness between the events and the suspect vaccine was not reported.
Patient didn't have any adverse events.  He came to the pharmacy to receive Moderma Vaccine.  Didn't realize he shouldn't have had it because of his age.  It is only for 18 and over.  Patient is 17.  However, patient is fine.  No problems.  Mother called MD and he said it was ok to give to the patient.    Now patient wants to receive dose #2.  Is it ok to give dose #2?
I am currently a nursing mother and 24 hours following the vaccine my infant son, born 1/22/2020 (approximately 13 months old) presented with a rash (trunk), nausea and vomiting, lethargy, decreased mobility, and irritability.  Approximately 48 hours following my vaccine he presented with a rash on the backs of his shoulders as well as on each of his cheeks as well as a fever of 101.5 degrees. The fever was treated easily with Tylenol and did not return after the 6 hour mark.  At 60 hours post vaccine, he was evaluated by his pediatrician in person and evaluated. He was specifically checked for ear infection (negative), strep (negative), and COVID-19 (results not in yet). After the care provider's assessment it was determined that a report should be made regarding the incident and that I should contact the CDC regarding his reaction.
This spontaneous report as received from a medical assistant (also reported as healthcare worker) refers to a patient of unknown age and unknown gender. The patient was vaccinated subcutaneously with an expired dose of 0.65 ml ZOSTAVAX (lot # 669405/1416Z, expiration date 21-JAN-2012) on 30-AUG-2012. No other co-suspects or concomitant medications were reported. No adverse effects reported. Additional information has been requested.